Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN) SEC News Jan. 06, 2026, 21:09 UTC 3 1 comments Anwer Khursheed 🟢 acquired 15.7K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000613 Comment Full text
Mersana Therapeutics (MRSN) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001298 Size: 30 KB Comment Full text
Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN) SEC News Jan. 06, 2026, 21:08 UTC 3 1 comments Director Fritz Frederick J. 🟢 acquired 5.9K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000611 Comment Full text
Insmed Inc (INSM) SEC News Jan. 06, 2026, 21:08 UTC 3 1 comments Bonstein Sara 🟢 acquired 42.9K shares (1 derivative) of INSMED Inc (INSM) at $177.12 ($5.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002 Comment Full text
Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN) SEC News Jan. 06, 2026, 21:08 UTC 4 1 comments Faller Douglas Vincent 🟢 acquired 12.7K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000610 Comment Full text
EyePoint Pharmaceuticals Inc (EYPT) SEC News Jan. 06, 2026, 21:08 UTC 3 1 comments Sanders Reginald J. 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002 Comment Full text
Biodexa Pharmaceuticals PLC (BDRX) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000191 Size: 18 KB Comment Full text
Biodexa Pharmaceuticals PLC (BDRX) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000193 Size: 20 KB Comment Full text
Biodexa Pharmaceuticals PLC (BDRX) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000192 Size: 18 KB Comment Full text
Biodexa Pharmaceuticals PLC (BDRX) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000189 Size: 17 KB Comment Full text
Biodexa Pharmaceuticals PLC (BDRX) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000190 Size: 18 KB Comment Full text
Biodexa Pharmaceuticals PLC (BDRX) SEC News Jan. 06, 2026, 21:08 UTC 3 0 comments New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000188 Size: 18 KB Comment Full text
Regeneron Pharmaceuticals Inc (REGN) SEC News Jan. 06, 2026, 21:08 UTC 3 1 comments Director Bassler Bonnie L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000004 Comment Full text
Celsion Corporation (the company was transformed to Imunon (IMNN)) (CLSN) SEC News Jan. 06, 2026, 21:07 UTC 3 1 comments Eylward Susan 🟢 acquired 8.3K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000609 Comment Full text
EyePoint Pharmaceuticals Inc (EYPT) SEC News Jan. 06, 2026, 21:07 UTC 3 1 comments Lurker Nancy 🟡 adjusted position in 40.0K shares (2 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000003 Comment Full text